Lineage Cell Therapeutics (LCTX) Current Leases (2014 - 2026)
Lineage Cell Therapeutics (LCTX) reported Current Leases of $833000.0 for Q1 2026, down 25.89% on a YoY basis from $1.1 million in Q1 2025, and up 2151.35% quarter-over-quarter from $37000.0 in Q4 2025.
Lineage Cell Therapeutics (LCTX) Current Leases (2014 - 2026) Analysis & Trends
Lineage Cell Therapeutics has reported Current Leases for 13 years, with the latest figure at $833000.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Leases fell 25.89% year-over-year to $833000.0; the trailing twelve-month figure through Mar 2026 stood at $833000.0 (down 25.89% YoY), and the FY2025 full-year result was $37000.0, down 32.73% from the prior year.
- Current Leases for Q1 2026 stood at $833000.0, up from $37000.0 in the prior quarter.
- The five-year high for Current Leases was $1.1 million in Q1 2025, with the low at $29000.0 in Q2 2022.
- Historically, Current Leases has averaged $401470.6 across 5 years, with a median of $54000.0 in 2023.
- Annual changes were most pronounced in 2022 — Current Leases slumped 96.06% — and 2025, when it soared 2193.88%.
- Lineage Cell Therapeutics' Current Leases stood at $916000.0 in 2022, then plunged by 94.32% to $52000.0 in 2023, then grew by 5.77% to $55000.0 in 2024, then tumbled by 32.73% to $37000.0 in 2025, then soared by 2151.35% to $833000.0 in 2026.
- The last three Current Leases figures came in at $833000.0 (Q1 2026), $37000.0 (Q4 2025), and $43000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Lineage Cell Therapeutics | 303.84 Mn | 239.94 Mn | 1.73 Mn | 833,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 833,000.00 |
| Dec 31, 2025 | 37,000.00 |
| Sep 30, 2025 | 43,000.00 |
| Jun 30, 2025 | 998,000.00 |
| Mar 31, 2025 | 1.12 Mn |
| Dec 31, 2024 | 55,000.00 |
| Sep 30, 2024 | 1.08 Mn |
| Jun 30, 2024 | 46,000.00 |
| Mar 31, 2024 | 49,000.00 |
| Dec 31, 2023 | 52,000.00 |
| Sep 30, 2023 | 881,000.00 |
| Jun 30, 2023 | 54,000.00 |
| Mar 31, 2023 | 51,000.00 |
| Dec 31, 2022 | 916,000.00 |
| Sep 30, 2022 | 543,000.00 |
| Jun 30, 2022 | 29,000.00 |
| Mar 31, 2022 | 31,000.00 |
| Dec 31, 2021 | 801,000.00 |
| Sep 30, 2021 | 801,000.00 |
| Jun 30, 2021 | 17,000.00 |